Curcumin and its formulations: Potential anti-cancer agents

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 3, 2012, Pages 210-218

  Ji, Jun Ling ^a   Huang, Xian Feng ^a,b   Zhu, Hai Liang ^a,b  

^a CHANGZHOU UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Anti cancer; Chemoprevention; Curcumin; Formulation

Indexed keywords

ALPHA6BETA4 INTEGRIN; ANTINEOPLASTIC AGENT; CURCUMIN; CURCUMIN GLUCURONOSIDE; CXCL11 CHEMOKINE; CYCLOOXYGENASE 2; DIHYDROCURCUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; HEXAHYDROCURCUMIN; HEXAHYDROXYCURCUMIN GLUCURONOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOSOME; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; NANOPARTICLE; PARAPROTEIN; PHOSPHOLIPID; PROTEIN BCL 2; PROTEIN KINASE B; STAT3 PROTEIN; TETRAHYDROCURCUMIN; TETRAHYDROXYCURCUMIN GLUCURONOSIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; WNT PROTEIN;

ABSENCE OF SIDE EFFECTS; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER; BONE MARROW CANCER; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CHEMOPROPHYLAXIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; G2 PHASE CELL CYCLE CHECKPOINT; HEAD AND NECK CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS; MICELLE; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; UTERINE CERVIX CANCER;

EID: 84863412160     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012800228733     Document Type: Review

References (88)

1. Zhou, H.; Beevers1, C.S.; Huang, S. The targets of curcumin. Curr. Drug Targets, 2011, 12, 332-347.
2. Ammon, H.P.; Wahl, M.A. Pharmacology of curcuma longa. Planta Medica, 1991, 57, 1-7.
3. Aggarwal, B.B.; Harikumar, K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol., 2009, 41, 40-59.
4. Sharma, R.A.; Gescher, A.J.; Steward, W.P. Curcumin: the story so far. Eur. J. Cancer, 2005, 41, 1955-1968.
5. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., 2003, 23, 363-398.
6. Shishodia, S.; Sethi, G.; Aggarwal, B.B. Curcumin: getting back to the roots. Ann. N. Y. Acad. Sci., 2005, 1056, 206-217.
7. Gafner, S.; Lee, S.K.; Cuendet, M.; Barthelemy, S.; Vergnes, L.; Labidalle, S.; Mehta, R.G.; Boone, C.W.; Pezzuto, J.M. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry, 2004, 65, 2849-2859.
8. Hong, J.; Bose, M.; Ju, J.; Ryu, J.H.; Chen, X.; Sang, S.; Lee, M.J.; Yang, C.S. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 2004, 25, 1671-1679.
9. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett., 2008, 267, 133-164.
10. Hatcher, H.; Planalp, R.; Cho, J.; Torti, F.M.; Torti, S.V. Curcumin: from ancient medicine to current clinical trials. Cell Mol. Life Sci., 2008, 65, 1631-1652.
11. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, 4, 807-818.
12. Asai, A.; Miyazawa, T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sciences, 2000, 67, 2785-2793.
13. Anand, P.; Thomas, S.G.; Kunnumakkara, A.B.; Sundaram, C.; Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Misra, K.; Priyadarsini, I.K.; Rajasekharan, K.N.; Aggarwal, B.B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol., 2008, 76, 1590-1611.
14. Kurien, B.T.; Singh, A.; Matsumoto, H.; Scofield, R.H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol., 2007, 5, 567-576.
15. Liu, J.Y.; Lin, S.J.; Lin, J.K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol- 13-acetate in NIH 3T3 cells. Carcinogenesis, 1993, 14, 857-861.
16. Huang, T.S.; Lee, S.C.; Lin, J.K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci., U. S. A. 1991, 88, 5292-5296.
17. Huang, M.T.; Lysz, T.; Ferraro, T.; Abidi, T.F.; Laskin, J.D.; Conney, A.H. Inhibitory effects of curcumin on in Vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res., 1991, 51, 813-819.
18. Bhaumik, S.; Anjum, R.; Rangaraj, N.; Pardhasaradhi, B.V.; Khar, A. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett., 1999, 456, 311-314.
19. Zhang, F.; Altorki, N.K.; Mestre, J.R.; Subbaramaiah, K.; Dannenberg, A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 1999, 20, 445-451.
20. Sugimoto, K.; Hanai, H.; Tozawa, K.; Aoshi, T.; Uchijima, M.; Nagata, T.; Koide, Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology, 2002, 123, 1912-1922.
21. Camacho-Barquero, L.; Villegas, I.; Sanchez-Calvo, J.M.; Talero, E.; Sánchez-Fidalgo, S.; Motilva, V.; Alarcón de la Lastra, C. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int. Immunol., 2007, 7, 333-342.
22. John, A.; Tuszynski, G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res., 2001, 7, 14-23.
23. Park, C.H.; Hahm, E.R.; Park, S.; Kim, H.K.; Yang, C.H. The inhibitory mechanism of curcumin and its derivative against betacatenin/ Tcf signaling. FEBS Lett., 2005, 579, 2965-2971.
24. Woo, J.H.; Kim, Y.H.; Choi, Y.J.; Kim DG, Lee K.S.; Bae, J.H.; Min, D.S.; Chang, J.S.; Jeong, Y.J.; Lee, Y.H.; Park, J.W.; Kwon, T.K. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 2003, 24, 1199-1208.
25. Mukhopadhyay, A.; Banerjee, S.; Stafford, L.J.; Xia, C.; Liu, M.; Aggarwal, B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene, 2002, 21, 8852-8862.
26. Anto, R.J.; Maliekal, T.T.; Karunagaran, D. L-929 cells harboring ectopically expressed RelA resist curcumininduced apoptosis. J. Biol. Chem., 2000, 275, 15601-15604.
27. Nagabhushan, M.; Bhide, S.V. Curcumin as an inhibitor of cancer. J. Am. Coll. Nutr., 1992, 11, 192-198.
28. Soni, K.B.; Kuttan, R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J. Physiol. Pharmacol., 1992, 36, 273-275.
29. Shishu, S.A.; Kaur, I.P. Inhibitory effect of curcumin and its natural analogues on genotoxicity of heterocyclic amines from cooked food. Indian J. Exp. Biol., 2002, 40, 1365-1372.
30. Soung, Y.H.; Chung, J. Curcumin inhibition of the functional interaction between integrin α6β4 and the epidermal growth factor receptor. Mol. Cancer Ther., 2011, 10, 883-891.
31. Kim, H.I.; Huang, H.; Cheepala, S.; Huang, S.; Chung, J. Curcumin inhibition of integrin (α6β4)-dependent breast cancer cell motility and invasion. Cancer Prev. Res., 2008, 1, 385-391.
32. Yoon, M.J.; Kim, E.H.; Lim, J.H.; Kwon, T.K.; Choi, K.S. Superoxide anion and proteasomal dysfunction contribute to curcumininduced paraptosis of malignant breast cancer cells. Free Rad Biol. Med., 2010, 48, 713-726.
33. Narasimhan, M.; Ammanamanchi, S. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Cancer Res., 2008, 68, 5185-5192.
34. Bachmeier, B.E.; Mohrenz, I.V.; Mirisola, V.; Schleicher, E.; Romeo, F.; Hoehneke, C.; Jochum, M.; Nerlich, A.G.; Pfeffer, U. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFκB. Carcinogenesis, 2008, 29, 779-789.
35. Teiten, M.H.; Gaascht, F.; Cronauer, M.; Henry, E.; Dicato, M.; Diederich, M. Anti-proliferative potential of curcumin in androgendependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int. J. Oncol., 2011, 38, 603-611.
36. Subramaniam, D.; Ramalingam, S.; Linehan, D.C.; Dieckgraefe, B.K.; Postier, R.G.; Houchen, C.W.; Jensen, R.A.; Anant, S. RNA binding protein CUGBP2/CELF2 mediates curcumin -induced mitotic catastrophe of pancreatic cancer cells. PLoS One, 2011, 6, e16958.
37. Jutooru, I.; Chadalapaka, G.; Lei, P.; Safe, S. Inhibition of NFκB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J. Biol. Chem., 2010, 285, 25332-25344.
38. Glienke, W.; Maute, L.; Wicht, J.; Bergmann, L. Cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Investi., 2010, 28, 166-171.
39. Yu, S.; Shen, G.; Khor, T.O.; Kim, J.H.; Kong, A.N.T. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol. Cancer Ther., 2008, 7, 2609-2620.
40. Sun, M.; Estrov, Z.; Ji, Y.; Coombes, K.R.; Harris, D.H.; Kurzrock, R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther., 2008, 7, 464-473.
41. Cai, X.Z.; Wang, J.; Li, X.D.; Wang, G.L.; Liu, F.N.; Cheng, M.S.; Li, Feng. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol. Ther., 2009, 8, 1360-1368.
42. Watson, J.L.; Hill, R.; Yaffe, P.B.; Greenshields, A.; Walsh, M.; Lee, P.W.; Giacomantonio, C.A.; Hoskin, D.W. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett., (Shannon, Ireland) 2010, 297, 1-8.
43. Pongrakhananon, V.; Nimmannit, U.; Luanpitpong, S.; Rojanasakul, Y.; Chanvorachote, P. Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation. Apoptosis, 2010, 15, 574-585.
44. Lin, S.S.; Lai, K.C.; Hsu, S.C.; Yang, J.S.; Kuo, C.L.; Lin, J.P.; Ma, Y.S.; Wu, C.C.; Chung, J.G. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett., (Shannon, Ireland) 2009, 285, 127-133.
45. Koeberle, A.; Northoff, H.; Werz, O. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol. Cancer Ther., 2009, 8, 2348-2355.
46. Lin, S.S.; Huang, H.P.; Yang, J.S.; Wu, J.Y.; Hsai, T.C.; Lin, C.C.; Lin, C.W.; Kuo, C.L.; Gibson Wood, W.; Chung, J.G. DNA damage and endoplasmic reticulum stress mediated curcumin -induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrialdependent pathway. Cancer Lett., (Shannon, Ireland) 2008, 272, 77-90.
47. Chen, H.W.; Lee, J.Y.; Huang, J.Y.; Wang, C.C.; Chen, W.J.; Su, S.F. Huang, C.W.; Ho, C.C.; Chen, J.J.W.; Tsai, M.F.; Yu, S.L.; Yang, P.C. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res., 2008, 68, 7428-7438.
48. Maher, D.M.; Bell, M.C.; O'Donnell, E.A.; Gupta, B.K.; Jaggi, M.; Chauhan, S.C. Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a] pyrene-induced upregulation of HPV E7. Mol. Carcinogenesis, 2011, 50, 47-57.
49. Javvadi, P.; Segan, A.T.; Tuttle, S.W.; Koumenis, C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol., 2008, 73, 1491-1501.
50. Seo, J.H.; Jeong, K.J.; Oh, W.J.; Sul, H.J.; Sohn, J.S.; Kim, Y.K.; Cho, D.Y.; Kang, J.K.; Park, C.G.; Lee, H.Y. Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin. Cancer Lett., (Shannon, Ireland) 2010, 288, 50-56.
51. Watson, J.L.; Greenshields, A.; Hill, R.; Hilchie, A.; Lee, P.W.; Giacomantonio, C.A.; Hoskin, D.W. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol. Carcinogenesis, 2010, 49, 13-24.
52. Bakhshi, J.; Weinstein, L.; Poksay, K.S.; Nishinaga, B.; Bredesen, D.E.; Rao, R.V. Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin. Apoptosis, 2008, 13, 904-914.
53. Wang, L.; Shen, Y.; Song, R.; Sun, Y.; Xu, J.; Xu, Q. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol. Pharmacol., 2009, 76, 1238-1245.
54. Bill, M.A.; Bakan, C.; Benson, D.M.J.; Fuchs, J.; Young, G.; Lesinski, G.B. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol. Cancer Ther., 2009, 8, 2726-2735.
55. Kamat, A.M.; Tharakan, S.T.; Sung, B.; Aggarwal, B.B. Curcumin potentiates the antitumor effects of bacillus calmette-guerin against bladder cancer through the downregulation of NF-κB and upregulation of TRAIL receptors. Cancer Res., 2009, 69, 8958-8966.
56. Hussain, A.R.; Ahmed, M.; Al-Jomah, N.A.; Khan, A.S.; Manogaran, P.; Sultana, M.; Abubaker, J.; Platanias, L.C.; Al-Kuraya, K.S.; Uddin, S. Curcumin suppresses constitutive activation of nuclear factor-κB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther., 2008, 7, 3318-3329.
57. Chadalapaka, G.; Jutooru, I.; Chintharlapalli, S.; Papineni, S.; Smith, R.; Li, X.; Safe, S. Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res., 2008, 68, 5345-5354.
58. Mackenzie, G.G.; Queisser, N.; Wolfson, M.L.; Fraga, C.G.; Adamo, A.M.; Oteiza, P.I. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells. Int. J. Cancer, 2008, 123, 56-65.
59. Choi, B.H.; Kim, C.G.; Bae, Y.S.; Lim, Y.; Lee, Y.H.; Shin, S.Y. p21Waf1/Cip1 Expression by curcumin in U-87MG human glioma cells: Role of early growth response-1 expression. Cancer Res., 2008, 68, 1369-1377.
60. Sun, Z.J.; Chen, G.; Zhang, W.; Hu, X.; Liu, Y.; Zhou, Q.; Zhu L.X.; Zhao, Y.F. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-Kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma. Mol. Pharmacol., 2011, 79, 106-118.
61. Wang, L.; Wang, L.; Song, R.; Shen, Y.; Sun, Y.; Gu, Y.; Shu, Y.; Xu, Q. Targeting sarcoplasmic/endoplasmic reticulum Ca2+- ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol. Cancer Ther., 2011, 10, 461-471.
62. Chakravarti, N.; Kadara, H.; Yoon, D.J.; Shay, J.W.; Myers, J.N.; Lotan, D.; Sonenberg, N.; Lotan, R. Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells. Cancer Prev. Res., 2010, 3, 331-338.
63. Elamin, M.H.; Shinwari, Z.; Hendrayani, S.F.; Al-Hindi, H.; Al-Shail, E.; Khafaga, Y.; Al-Kofide, A.; Aboussekhra, A. Curcumin inhibits the sonic hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol. Carcinogenesis, 2010, 49, 302-314.
64. Tian, B.; Wang, Z.; Zhao, Y.; Wang, D.; Li, Y.; Ma, L.; Li, X.; Li, J.; Xiao, N.; Tian, J.; Rodriguez, R. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett., (Shannon, Ireland) 2008, 264, 299-308.
65. Milacic, V.; Banerjee, S.; Landis-Piwowar, K.R.; Sarkar, F.H.; Majumdar, A.P.N.; Dou, Q.P. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res., 2008, 68, 7283-7292.
66. Perry, M.C.; Demeule, M.; Regina, A.; Moumdjian, R.; Beliveau, R. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol. Nut. Food Res., 2010, 54, 1192-1201.
67. Weissenberger, J.; Priester, M.; Bernreuther, C.; Rakel, S.; Glatzel, M.; Seifert, V.; Koegel, D. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway. Clin. Cancer Res., 2010, 16, 5781-5795.
68. Villegas, I.; Sanchez-Fidalgo, S.; de la Lastra, C.A. Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice. Mol. Nutr. Food Res., 2011, 55, 259-267.
69. Clark, C.A.; McEachern, M.D.; Shah, S.H.; Rong, Y.; Rong, X.; Smelley, C.L.; Caldito, G.C.; Abreo, F.W.; Nathan, C.O. Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma. Cancer Prev. Res., 2010, 3, 1586-1595.
70. Chen, L.X.; He, Y.J.; Zhao, S.Z.; Wu, J.G.; Wang, J.T.; Zhu, L.M.; Lin, T.T.; Sun, B.C.; Li, X.R. Inhibition of tumor growth and vasculogenic mimicry by curcumin through downregulation of the EphA2/Pl3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol. Ther., 2011, 11, 229-235.
71. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y.F.; Shen, T.S.; Ko, J.Y.; Lin, J.T.; Lin, B.R.; Ming-Shiang, W.; Yu, H.S.; Jee, S.H.; Chen, G.S.; Chen, T.M.; Chen, C.A.; Lai, M.K.; Pu, Y.S.; Pan, M.H.; Wang, Y.J.; Tsai, C.C.; Hsieh, C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res., 2001, 21, 2895-2900.
72. William, P.S.; Andreas J.G. Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research. Mol. Nutr. Food Res., 2008, 52, 1005-1009.
73. Kunnumakkara, A.B.; Anand, P.; Aggarwal, B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett., 2008, 269, 199-225.
74. Bar-Sela, G.; Epelbaum, R.; Schaffer, M. Curcumin as an Anti- Cancer Agent: Review of the gap between basic and clinical applications. Curr. Med. Chem., 2010, 17, 190-197.
75. Carroll, R.E.; Benya, R.V.; Turgeon, D.K.; Vareed, S.; Neuman, M.; Rodriguez, L.; Kakarala, M.; Carpenter, P.M.; McLaren, C.; Meyskens, Frank, J.; Brenner, D.E. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res., 2011, 4, 354-364.
76. Golombick, T.; Diamond, T.H.; Badmaev, V.; Manoharan, A.; Ramakrishna, R. The Potential Role of curcumin in patients with monoclonal gammopathy of undefined significance-Its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin. Cancer Res., 2009, 15, 5917-5922.
77. Dhillon, N.; Aggarwal, B.B.; Newman, R.A.; Wolff, R.A.; Kunnumakkara, A.B.; Abbruzzese, J.L.; Ng, C.S.; Badmaev, V.; Kurzrock, R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res., 2008, 14, 4491-4499.
78. Li, J.; Wang, Y.; Yang, C.; Wang, P.; Oelschlager, D.K.; Zheng, Y.; Tian, D.A.; Grizzle, W.E.; Buchsbaum, D.J.; Wan, M. Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol. Pharmacol., 2009, 76, 81-90.
79. Anand, P.; Nair, H.B.; Sung, B.; Kunnumakkara, A.B.; Yadav, V.R.; Tekmal, R.R.; Aggarwal, B.B. Design of curcumin -loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol., 2010, 79, 330-338.
80. Shahani, K.; Swaminathan, S.K.; Freeman, D.; Blum, A.; Ma, L.N.; Panyam, J. Injectable Sustained Release Microparticles of Curcumin: A new concept for cancer chemoprevention. Cancer Res., 2010, 70, 4443-4452.
81. Mohanty, C.; Sahoo, S.K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials, 2010, 31, 6597-6611.
82. Bisht, S.; Mizuma, M.; Feldmann, G.; Ottenhof, N.A.; Hong, S.M.; Pramanik, D.; Chenna, V.; Karikari, C.; Sharma, R.; Goggins, M.G.; Rudek, M.A.; Ravi, R.; Maitra, A.; Maitra, A. Systemic administration of polymeric nanoparticle-encapsulated curcumin (nanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol. Cancer Ther., 2010, 9, 2255-2264.
83. Yadav, V.R.; Prasad, S.; Kannappan, R.; Ravindran, J.; Chaturvedi, M.M.; Vaahtera, L.; Parkkinen, J.; Aggarwal, B.B. Cyclodextrincomplexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem. Pharmacol., 2010, 80, 1021-1032.
84. Song, Z.; Feng, R.; Sun, M.; Guo, C.; Gao, Y.; Li, L.; Zhai, G. Curcumin -loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo. Journal of Colloid and Interface Science, 2011, 354, 116-123.
85. Kakkar, V.; Singh, S.; Singla, D.; Kaur, I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nutr. Food Res., 2011, 55, 495-503.
86. Pandelidou, M.; Dimas, K.; Georgopoulos, A.; Hatziantoniou, S.; Demetzos, C. Preparation and characterization of lyophilised EGG PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. J. Nanosci. Nanotechnol., 2011, 11, 1259-1266.
87. Lim, K.J.; Bisht, S.; Bar, E.E.; Maitra, A.; Eberhart, C.G. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol. Ther., 2011, 11, 464-473.
88. Gou, M.L.; Men, K.; Shi, H.S.; Xiang, M.L.; Zhang, J.; Song, J.; Long, J.L.; Wan, Y.; Luo, F.; Zhao, X.; Qian, Z.Y. Curcuminloaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale, 2011, 3, 1558-1567.